Immatics (IMTX) News Today $5.83 -0.09 (-1.50%) Closing price 03:59 PM EasternExtended Trading$5.82 -0.01 (-0.19%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock IMTX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Zimmer Partners LP Cuts Stake in Immatics N.V. $IMTXSeptember 12 at 6:40 AM | marketbeat.comImmatics (NASDAQ:IMTX) Trading Down 5.7% - Time to Sell?September 10 at 3:14 PM | marketbeat.comImmatics N.V. (NASDAQ:IMTX) Receives Consensus Rating of "Moderate Buy" from AnalystsSeptember 10 at 2:43 AM | americanbankingnews.comTrexquant Investment LP Invests $783,000 in Immatics N.V. $IMTXSeptember 9 at 3:33 AM | marketbeat.comImmatics N.V. (NASDAQ:IMTX) Receives Average Rating of "Moderate Buy" from AnalystsSeptember 7, 2025 | marketbeat.comImmatics (NASDAQ:IMTX) Stock Price Up 8% - Here's What HappenedSeptember 4, 2025 | marketbeat.comVestal Point Capital LP Raises Position in Immatics N.V. $IMTXSeptember 4, 2025 | marketbeat.comImmatics N.V. $IMTX Shares Sold by Frazier Life Sciences Management L.P.September 4, 2025 | marketbeat.comImmatics N.V. $IMTX Shares Sold by Paradigm Biocapital Advisors LPSeptember 2, 2025 | marketbeat.comRussell Investments Group Ltd. Acquires New Position in Immatics N.V. $IMTXSeptember 2, 2025 | marketbeat.comImmatics (NASDAQ:IMTX) Stock Price Down 4.8% - Here's What HappenedAugust 27, 2025 | marketbeat.comWellington Management Group LLP Sells 1,834,324 Shares of Immatics N.V. $IMTXAugust 26, 2025 | marketbeat.comImmatics N.V. $IMTX Shares Bought by T. Rowe Price Investment Management Inc.August 25, 2025 | marketbeat.comAberdeen Group plc Boosts Stock Holdings in Immatics N.V. $IMTXAugust 23, 2025 | marketbeat.comImmatics (NASDAQ:IMTX) Shares Down 7.8% - Should You Sell?August 21, 2025 | marketbeat.comImmatics N.V. Reports Q2 2025 Financial ResultsAugust 20, 2025 | msn.comAnalysts Set Expectations for Immatics FY2025 EarningsAugust 19, 2025 | marketbeat.comQ3 Earnings Estimate for Immatics Issued By Leerink PartnrsAugust 19, 2025 | marketbeat.comImmatics N.V. (NASDAQ:IMTX) Analysts Just Slashed This Year's EstimatesAugust 18, 2025 | finance.yahoo.comImmatics (NASDAQ:IMTX) Issues Quarterly Earnings ResultsAugust 17, 2025 | marketbeat.comLeerink Partners Reaffirms Their Buy Rating on Immatics (IMTX)August 17, 2025 | theglobeandmail.comImmatics (NASDAQ:IMTX) Shares Up 6.9% - Here's What HappenedAugust 17, 2025 | marketbeat.comImmatics (NASDAQ:IMTX) Shares Gap Down After Earnings MissAugust 15, 2025 | marketbeat.comImmatics Reports Q2 2025 Financial Results and Business UpdateAugust 13, 2025 | msn.comImmatics Announces Second Quarter 2025 Financial Results and Business UpdateAugust 13, 2025 | globenewswire.comImmatics N.V. (NASDAQ:IMTX) Receives Average Recommendation of "Buy" from AnalystsAugust 12, 2025 | marketbeat.comXTX Topco Ltd Takes Position in Immatics N.V. (NASDAQ:IMTX)August 7, 2025 | marketbeat.comImmatics (IMTX) Projected to Post Earnings on TuesdayAugust 6, 2025 | marketbeat.comImmatics (NASDAQ:IMTX) Trading Up 9.6% - Still a Buy?July 24, 2025 | marketbeat.comImmatics N.V. (NASDAQ:IMTX) Receives Consensus Recommendation of "Buy" from BrokeragesJuly 17, 2025 | marketbeat.comImmatics (NASDAQ:IMTX) Shares Up 2.9% - What's Next?July 17, 2025 | marketbeat.comHere Is What You Need To Know Before Investing In Immatics N.V. (IMTX)July 9, 2025 | insidermonkey.comImmatics N.V. (IMTX) Earnings Surprise Summary (EPS) - Seeking AlphaJune 26, 2025 | seekingalpha.comImmatics N.V. (NASDAQ:IMTX) Given Average Rating of "Buy" by BrokeragesJune 22, 2025 | marketbeat.comImmatics (NASDAQ:IMTX) Shares Down 3.8% - Here's WhyJune 18, 2025 | marketbeat.comImmatics N.V. Shareholders Approve Key Resolutions at June 2025 AGMJune 18, 2025 | tipranks.comImmatics (NASDAQ:IMTX) Shares Up 4.4% - Here's What HappenedJune 12, 2025 | marketbeat.comImmatics (NASDAQ:IMTX) Sees Unusually-High Trading Volume - Here's What HappenedJune 11, 2025 | marketbeat.comCantor Fitzgerald Forecasts Immatics FY2026 EarningsJune 10, 2025 | marketbeat.comImmatics (NASDAQ:IMTX) Shares Down 4.9% - Should You Sell?June 9, 2025 | marketbeat.comMillennium Management LLC Has $1.11 Million Holdings in Immatics (NASDAQ:IMTX)June 5, 2025 | marketbeat.comImmatics: Taking Off On A PRAME RocketshipJune 4, 2025 | seekingalpha.comImmatics rises on data from early stage cell therapy trialJune 2, 2025 | msn.comImmatics Presents Promising IMA203 Data at ASCO 2025June 2, 2025 | tipranks.comImmatics (IMTX) Shares Promising Data from IMA203 Melanoma Trials | IMTX Stock NewsJune 1, 2025 | gurufocus.comImmatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to ...May 31, 2025 | gurufocus.comImmatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to ...May 31, 2025 | gurufocus.comImmatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to ...May 31, 2025 | gurufocus.comImmatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic MelanomaMay 31, 2025 | globenewswire.comWellington Management Group LLP Grows Position in Immatics (NASDAQ:IMTX)May 30, 2025 | marketbeat.com Get Immatics News Delivered to You Automatically Sign up to receive the latest news and ratings for IMTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IMTX Media Mentions By Week IMTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMTX News Sentiment▼1.030.93▲Average Medical News Sentiment IMTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMTX Articles This Week▼64▲IMTX Articles Average Week Get the Latest News and Ratings for IMTX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Immatics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies NewAmsterdam Pharma News Today Viking Therapeutics News Today Xenon Pharmaceuticals News Today AMNEAL PHARMACEUTICALS News Today Scholar Rock News Today Immunovant News Today MorphoSys News Today HUTCHMED News Today Bausch Health Cos News Today Organon & Co. News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMTX) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s new AI play could hand regular Americans a Tesla‑like paydayElon Musk just launched his boldest AI project yet... And if history is any guide — it could make early inv...Behind the Markets | SponsoredCollege grad makes $64,000 a monthNothing hurts like a missed opportunity... And with AI stocks like Nvidia, Palantir, and Oracle continuing...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immatics N.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immatics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IMTX Stock Alerts